<DOC>
	<DOCNO>NCT01384617</DOCNO>
	<brief_summary>The objective clarify Roux-en-Y anastomosis pancreatic stump decrease pancreatic fistula follow distal pancreatectomy , compare stapling closure pancreatic stump .</brief_summary>
	<brief_title>Trial Assessing Roux-en-Y Anastomosis Pancreatic Stump Prevent Pancreatic Fistula Following Distal Pancreatectomy</brief_title>
	<detailed_description>The objective study clarify Roux-en-Y anastomosis pancreatic stump prevents pancreatic fistula distal pancreatectomy ( DP ) compare stapling closure pancreatic stump prospective randomize controlled trail . Various method technique treat surgical stump remnant pancreas report reduce pancreatic fistula DP . However , appropriate surgical stump closure DP still controversial . The primary endpoint trial define incidence pancreatic fistula .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Adenoma , Islet Cell</mesh_term>
	<mesh_term>Pancreatic Fistula</mesh_term>
	<mesh_term>Pancreatic Pseudocyst</mesh_term>
	<criteria>1. disease pancreatic body tail 2 . PS ( ECOG Performance Status Scale ) :01 3 . Age : 20 year old 4. distant metastasis diagnose preoperatively . Eligible clinical study distal pancreatectomy contribute favorable prognosis even patient pancreatic neuroendocrine cancer liver metastasis . 5 . Adequate organ function fill follow criterion within two week enrollment : 1.White blood cellï¼š &gt; 3,500/mm3 &lt; 12,000/mm3 2.Neutrophilic leukocyte &gt; 2,000/mm3 3.Platelet &gt; 100,000/mm3 4.Hemoglobin &gt; 9.0g/dL 5.Total bilirubin &lt; 2.0mg/dL 6.AST ALT &lt; 150IU/L 7.Creatinine &lt; 1.5mg/dL 6 ) Patients provide write informed consent 1 . Patients severe liver cirrhosis active hepatitis 2 . Patients respiratory illness require oxygen administration 3 . .Patients chronic renal failure require dialysis 4 . Patients active duplicative malignant disease affect adverse event 5 . Others , patient unfit study determine attend physician</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>distal pancreatectomy</keyword>
	<keyword>pancreatic fistula</keyword>
	<keyword>pancreaticojejunostomy</keyword>
	<keyword>Roux-en-Y anastomosis</keyword>
	<keyword>staple closure</keyword>
</DOC>